Sei Investments Co. Purchases 4,082 Shares of Cardinal Health, Inc. $CAH

Key Points

• Sei Investments Co. increased its stake in Cardinal Health to approximately $60.96 million, owning around 0.20% of the company after purchasing additional shares in the first quarter.
• Cardinal Health reported $2.08 earnings per share for its latest quarter, exceeding analysts' expectations, although its revenue of $60.16 billion fell short of estimates.
• Cardinal Health now has an average analyst rating of "Moderate Buy" with a consensus price target of $163.20 from 13 buy ratings and 3 hold ratings.

Sei Investments Co. increased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 0.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 465,472 shares of the company's stock after acquiring an additional 4,082 shares during the quarter. Sei Investments Co. owned approximately 0.20% of Cardinal Health worth $60,961,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Sterling Capital Management LLC increased its stake in shares of Cardinal Health by 28.0% in the fourth quarter. Sterling Capital Management LLC now owns 8,201 shares of the company's stock valued at $970,000 after purchasing an additional 1,796 shares during the period. Townsquare Capital LLC increased its stake in shares of Cardinal Health by 31.2% in the fourth quarter. Townsquare Capital LLC now owns 4,229 shares of the company's stock valued at $500,000 after purchasing an additional 1,005 shares during the period. SageView Advisory Group LLC acquired a new stake in shares of Cardinal Health in the fourth quarter valued at approximately $447,000. Cohen & Steers Inc. increased its stake in shares of Cardinal Health by 5.4% during the fourth quarter. Cohen & Steers Inc. now owns 2,281 shares of the company's stock valued at $270,000 after acquiring an additional 116 shares during the period. Finally, Mariner LLC increased its stake in shares of Cardinal Health by 5.4% during the fourth quarter. Mariner LLC now owns 52,160 shares of the company's stock valued at $6,169,000 after acquiring an additional 2,685 shares during the period. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Trading Down 0.5%

Cardinal Health stock traded down $0.7240 on Tuesday, reaching $149.0060. 948,055 shares of the stock were exchanged, compared to its average volume of 2,409,618. The stock has a market cap of $35.58 billion, a PE ratio of 23.12, a PEG ratio of 1.26 and a beta of 0.67. Cardinal Health, Inc. has a twelve month low of $106.54 and a twelve month high of $168.44. The firm has a fifty day moving average price of $159.55 and a two-hundred day moving average price of $144.91.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.03 by $0.05. The company had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business's revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be paid a $0.5107 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.4%. Cardinal Health's payout ratio is 31.63%.

Analyst Ratings Changes

CAH has been the topic of a number of research analyst reports. Leerink Partners lowered their price objective on shares of Cardinal Health from $188.00 to $186.00 and set an "outperform" rating on the stock in a research note on Tuesday, August 12th. Bank of America lifted their price target on shares of Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a research report on Tuesday, June 10th. Morgan Stanley reaffirmed an "overweight" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. UBS Group reaffirmed a "buy" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Finally, Wells Fargo & Company reissued an "overweight" rating and set a $185.00 target price (up previously from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Cardinal Health currently has a consensus rating of "Moderate Buy" and an average price target of $163.20.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.